Protein may represent a switch to turn off B cell lymphoma
Researchers studying the molecular signals that drive a specific type of lymphoma have discovered a key biological pathway leading to this type of cancer. Cancerous cells have been described as being "addicted" to certain ...
Cancer
May 07, 2012 |
5 / 5 (1) |
0
Lymphoma therapy could deliver a double punch
B cell lymphomas are a group of cancers of that originate in lymphoid tissue from B cells, the specialized immune cell type that produces antibodies. The development of B cell lymphoma is associated with several known genetic ...
Cancer
Apr 30, 2012 |
5 / 5 (2) |
0
Antibodies to intracellular cancer antigens combined with chemotherapy enhance anti-cancer immunity
An international team of scientists in Japan, Switzerland, and the United States has confirmed that combining chemotherapy and immunotherapy in cancer treatment enhances the immune system's ability to find and eliminate cancer ...
Cancer
Feb 13, 2012 |
5 / 5 (1) |
0
More intensive chemotherapy dramatically improves recurrence, survival in younger patients with aggressive lymphoma
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Cancer
Nov 24, 2011 |
not rated yet |
0
Targeting the Ewing sarcoma family of tumors
The Max Cure Foundation and the Samuel Waxman Cancer Research Foundation have partnered to establish a fund in pediatric cancer research. With that goal in mind, the two Foundations are proud to announce the award of $100,000 ...
Cancer
Jul 01, 2011 |
not rated yet |
0
New research provides breakthrough in understanding common cancer
Researchers from the University of Sheffield have discovered valuable insight into how people develop B-cell lymphoma, one of the most common cancers in the UK.
Cancer
Jun 09, 2011 |
1 / 5 (1) |
0
|
- Pages: 1 2
